---
$id: https://graph.org.ai/products/commodity/51241122
$type: Product
source: UNSPSC
code: "51241122"
title: "Pegaptanib"
class: "51241100"
classTitle: "Ophthalmic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pegaptanib

**UNSPSC Code**: 51241122
**Class**: [Ophthalmic agents](Ophthalmic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an angiogenesis inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2H1PA8H1EN. European Medicines Agency schedules Pegaptanib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25196. Pegaptanib generally arises in the molecular formula C15H28N3O6(C2H4O)N(C2H4O)N. The term PEGAPTANIB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 17, no. 2, 2003, list 49.) Most nations schedule pegaptanib under HS 39072021 and SITC 57419. As of Q4 2014, PEGAPTANIB remains the US FDA Preferred Term for this commodity. Pegaptanib bears US NLM identifiers UMLS ID C1531015 and NCI Concept Code C90657. SMILES: COCCOC(=O)NCCCCC(C(=O)NCCCCCCCOP(=O)(C)O)NC(=O)OCCOC.

